Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1

Abstract

Background. The aim of this review is to provide the information about molecular basis of hypoxia-induced chemoresistance, focusing on the possibility of diagnostic and therapeutic use. Results. Hypoxia is a common feature of tumors and represents an independent prognostic factor in many cancers. It is the result of imbalances in the intake and consumption of oxygen caused by abnormal vessels in the tumor and the rapid proliferation of cancer cells. Hypoxia-induced resistance to cisplatin, doxorubicin, etoposide, melphalan, 5-flouoruracil, gemcitabine, and docetaxel has been reported in a number of experiments. Adaptation of tumor cells to hypoxia has important biological effects. The most studied factor responsible for these effects is hypoxia-inducible factor-1 (HIF-1) that significantly contributes to the aggressiveness and chemoresistance of different tumors. The HIF-1 complex, induced by hypoxia, binds to target genes, thereby increasing the expression of many genes. In addition, the expression of hundreds of genes can be also decreased in response to hypoxia in HIF-1 dependent manner, but without the detection of HIF-1 in these genes' promoters. HIF-1 independent mechanisms for drug resistance in hypoxia have been described, however, they are still rarely reported. The first clinical studies focusing on diagnosis of hypoxia and on inhibition of hypoxia-induced changes in cancer cells are starting to yield results. Conclusions. The adaptation to hypoxia requires many genetic and biochemical responses that regulate one another. Hypoxia-induced resistance is a very complex field and we still know very little about it. Different approaches to circumvent hypoxia in tumors are under development.

The effects of cysplatin on human adipose tissue derived mesenchymal stromal cells under different oxygen levels

“…Кроме того, растущий объем экспериментальных данных свидетельствует о том, что в некоторых типах злокачественных образований положительные эффекты CPt заметно уменьшались в связи с условиями гипоксии. Многие из HIF-1 ин-дуцибельных молекул, таких как ростовые факторы, транспортеры (Glut-1, Mdr-1), антиапоптотический белок Bcl-2, прямо или опосредованно могут участво-вать в развитии резистентности к химиотерапевтиче-ским препаратам [25].…”

Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters

“…HIF1A is the central node that mediates activation of a number of different signaling pathways that alter metabolic pathways, induce invasiveness, promote chemoresistance, and lead to a poor prognosis of the patient 46 . HIF has been reported to participate in drug and radiotherapy resistance in cancer treatment.…”

Gene‑expression signature predicts survival benefit from postoperative chemoradiotherapy in head and neck squamous cell carcinoma

“…Indeed, we found that two gene sets involved in drug resistance were significantly enriched in the low-score phenotype. Hypoxia is commonly observed in many solid tumors including HNSCC, and is linked to chemo-resistance (19,20). Our results revealed that the low-score subtype was significantly enriched by a hypoxia-induced gene set in HNSCC (21).…”